2m 2m 2m 2m 2m 2m 2m
SEER-A (SEER)
NASDAQ
$1.86-$0.004 (-0.22%)
Price as of Jun 03, 2026 5:53 PM EDT- $102.8MMarket Cap
- -12.62%1-Year Change
- BiotechnologyIndustry
SEER-A (SEER)
$1.86-$0.004 (-0.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.2M -20.91% | 14.2M -14.95% | 16.7M +7.54% | 15.5M +134.14% | |
Cost of Revenue | 5.3M -25.00% | 7.1M -12.75% | 8.2M -2.92% | 8.4M +162.09% | |
Gross Profit | 8.5M +19.99% | 7.1M -17.06% | 8.5M +19.92% | 7.1M +107.88% | |
Sales and Marketing Expense | 42.6M -24.73% | 56.6M -4.04% | 59.0M +0.72% | 58.5M +27.90% | |
Research and Development Expense | -43.9M -13.27% | -50.6M -4.59% | -53.0M +15.77% | -45.8M +57.26% | |
Depreciation and Amortization Expense | 6.1M -1.17% | 6.2M +10.72% | 5.6M +41.50% | 3.9M +54.10% | |
Total Operating Expenses | 86.5M -19.32% | 107.2M -4.30% | 112.0M +7.32% | 104.3M +39.32% | |
Operating Profit | -78.0M -22.09% | -100.1M -3.25% | -103.5M +6.41% | -97.2M +36.04% | |
Interest Income | 11.5M -30.87% | 16.7M -6.18% | 17.8M +286.01% | 4.6M +1,311.66% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 11.5M -30.87% | 16.7M -6.18% | 17.8M +286.01% | 4.6M +1,413.82% | |
Total Nonoperating Income and Expense | 4.6M -66.23% | 13.6M -20.87% | 17.2M +302.58% | 4.3M +1,304.28% | |
Income before Taxes | -73.4M -15.15% | -86.5M -16.39% | -103.5M +6.41% | -97.2M +36.04% | |
Income Taxes | 201,000 +105.10% | 98,000 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -73.6M -15.01% | -86.6M +0.37% | -86.3M -7.20% | -93.0M +30.63% | |
Net Income from Continuing Operations Applicable to Common | -73.4M -15.15% | -86.5M +0.26% | -86.3M -7.20% | -93.0M +30.63% | |
Basic EPS and Net Income | -1.28 -7.91% | -1.39 +2.96% | -1.35 -9.40% | -1.49 +27.35% | |
Diluted EPS and Net Income | -1.28 -7.91% | -1.39 +2.96% | -1.35 -9.40% | -1.49 +27.35% | |
Basic Weighted Average Shares | 57.4M -7.86% | 62.3M -2.35% | 63.9M +2.27% | 62.4M +2.58% | |
Diluted Weighted Average Shares | 57.4M -7.86% | 62.3M -2.35% | 63.9M +2.27% | 62.4M +2.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 47.3M +16.03% | 40.8M +25.40% | 32.5M -38.92% | 53.2M -77.15% | |
Short-Term Investments | 138.6M -29.16% | 195.7M -31.04% | 283.7M -22.91% | 368.0M +120.03% | |
Cash and Cash Equivalents and Short-Term Investments | 185.9M -21.37% | 236.4M -25.24% | 316.2M -24.93% | 421.2M +5.29% | |
Total Current Assets | 201.5M -20.44% | 253.3M -23.35% | 330.5M -24.02% | 435.0M +5.66% | |
Accumulated Depreciation | 19.4M +15.53% | 16.8M +34.09% | 12.5M +60.32% | 7.8M +59.35% | |
Property and Plant and Equipment and Net | 14.8M -20.57% | 18.6M -16.30% | 22.2M +14.35% | 19.4M +48.30% | |
Total Long-Term Assets | 4.1M -50.53% | 8.3M +724.80% | 1.0M +17.43% | 855,000 +70.66% | |
Total Assets | 296.1M -19.23% | 366.6M -15.97% | 436.3M -10.59% | 487.9M -9.50% | |
Income Taxes Payable | 635,000 +34.82% | 471,000 -5.99% | 501,000 +49.55% | 335,000 -95.72% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 15.7M +2.37% | 15.3M +15.93% | 13.2M +5.07% | 12.6M -6.25% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 8,000 -83.33% | 48,000 -73.18% | 179,000 -44.06% | 320,000 -6.16% | |
Total Liabilities | 36.8M -5.77% | 39.0M -0.86% | 39.4M -3.84% | 40.9M +13.01% | |
Retained Earnings | -466.0M +18.76% | -392.4M +28.32% | -305.8M +39.31% | -219.5M +73.47% | |
Total Stockholders Equity | 259.3M -20.84% | 327.6M -17.47% | 396.9M -11.21% | 447.0M -11.12% | |
Total Shares Outstanding | 56.2M -4.92% | 59.1M -8.04% | 64.3M +1.40% | 63.4M +2.25% | |
Cash Flow | |||||
Cash from Operating Activities | -44.4M -3.60% | -46.1M -21.94% | -59.1M -2.82% | -60.8M +31.14% | |
Capital Expenditures | 1.8M -49.86% | 3.6M -50.96% | 7.3M -28.80% | 10.3M +48.30% | |
Cash from Investing Activities | 61.5M -6.54% | 65.9M +73.75% | 37.9M +130.89% | -122.7M -28.18% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -10.6M -8.06% | -11.5M -2,643.14% | 452,000 -88.39% | 3.9M -96.66% | |
Financials Ratio | |||||
Gross Margin | 52.39% +5.22% | 49.79% -2.48% | 51.05% +11.51% | 45.78% N/A | |
Operating Margin | -695.92% -1.49% | -706.43% +13.76% | -620.99% -1.05% | -627.61% N/A | |
Return on Assets | -22.21% +2.97% | -21.57% +15.54% | -18.67% +3.13% | -18.10% N/A | |
Return on Equity | -25.08% +4.92% | -23.91% +16.92% | -20.45% +4.46% | -19.57% N/A | |
Revenue Growth | -20.91% +39.86% | -14.95% -298.32% | 7.54% -94.38% | 134.14% N/A | |
Current Ratio | 12.84 -22.28% | 16.53 -33.89% | 25.00 -27.68% | 34.57 N/A | |
Cash Ratio | 3.01 +13.34% | 2.66 +8.17% | 2.46 -41.87% | 4.23 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow